Patients hospitalized with alcohol-related liver disease and prior bariatric surgery are more prone to develop acute-on-chronic liver failure.
alcohol consumption
alcohol use disorder
gastric bypass
metabolic surgery
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
17
08
2023
received:
19
06
2023
accepted:
29
08
2023
medline:
29
11
2023
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
ppublish
Résumé
Patients with a history of bariatric surgery (BS) are susceptible to developing alcohol use disorder. We and others have previously shown that these patients can develop severe alcohol-related liver disease (ARLD). Our aim was to describe the demographics, co-morbidities and mortality of a hospitalized population diagnosed with alcohol-related liver disease, in relation to BS. We included 299 patients hospitalized with ARLD at the Ghent University Hospital between 1 January 2018 and 31 December 2022. Clinical, biochemical and outcome data were retrospectively retrieved from the most recent hospitalization. Statistical analysis was performed using the t test, Mann-Whitney U and χ Thirteen per cent (39/299) of patients admitted with ARLD had a history of bariatric surgery, of whom 25 (64.1%) had undergone Roux-en-Y gastric bypass. Patients with a history of BS were predominantly female (76.9%), in contrast to the non-BS population (29.2%) (p < .0001), and despite being significantly younger (p < .0001) and had a similar survival (61.5% vs. 58.1%). Bariatric surgery and older age at diagnosis were both significantly associated with poorer transplant-free survival. The cause of death was acute-on-chronic liver failure in 73.3% of BS patients, compared to only 19.2% of those without a history of BS (p < .0001). The weekly amount of alcohol consumed (p = .012) and duration of use (p < .0001) were significantly lower/shorter in the BS population. BS patients hospitalized with ARLD are predominantly younger women with a lower cumulative alcohol consumption compared to those without prior BS. BS impacted transplant-free survival, with ACLF as the predominant cause of death in these patients.
Sections du résumé
BACKGROUND & AIMS
OBJECTIVE
Patients with a history of bariatric surgery (BS) are susceptible to developing alcohol use disorder. We and others have previously shown that these patients can develop severe alcohol-related liver disease (ARLD). Our aim was to describe the demographics, co-morbidities and mortality of a hospitalized population diagnosed with alcohol-related liver disease, in relation to BS.
METHODS
METHODS
We included 299 patients hospitalized with ARLD at the Ghent University Hospital between 1 January 2018 and 31 December 2022. Clinical, biochemical and outcome data were retrospectively retrieved from the most recent hospitalization. Statistical analysis was performed using the t test, Mann-Whitney U and χ
RESULTS
RESULTS
Thirteen per cent (39/299) of patients admitted with ARLD had a history of bariatric surgery, of whom 25 (64.1%) had undergone Roux-en-Y gastric bypass. Patients with a history of BS were predominantly female (76.9%), in contrast to the non-BS population (29.2%) (p < .0001), and despite being significantly younger (p < .0001) and had a similar survival (61.5% vs. 58.1%). Bariatric surgery and older age at diagnosis were both significantly associated with poorer transplant-free survival. The cause of death was acute-on-chronic liver failure in 73.3% of BS patients, compared to only 19.2% of those without a history of BS (p < .0001). The weekly amount of alcohol consumed (p = .012) and duration of use (p < .0001) were significantly lower/shorter in the BS population.
CONCLUSIONS
CONCLUSIONS
BS patients hospitalized with ARLD are predominantly younger women with a lower cumulative alcohol consumption compared to those without prior BS. BS impacted transplant-free survival, with ACLF as the predominant cause of death in these patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2743-2751Subventions
Organisme : Research Foundation - Flanders (FWO)
ID : 1801721N
Organisme : Research Foundation - Flanders (FWO)
ID : 1805718N
Organisme : Research Foundation - Flanders (FWO)
ID : 12R0321N
Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Karlsen TH, Sheron N, Zelber-Sagi S, et al. The EASL-lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2022;399(10319):61-116. doi:10.1016/S0140-6736(21)01701-3/ATTACHMENT/82513520-DAB3-430E-A196-83F57E6FC6C3/MMC1.PDF
Bertola A. Mouse model of alcoholic steatohepatitis. Methods Mol Biol. 2020;2164:145-157. doi:10.1007/978-1-0716-0704-6_15
Thursz M, Gual A, Lackner C, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-181. doi:10.1016/J.JHEP.2018.03.018
Blackburn AN, Hajnal A, Leggio L. The gut in the brain: the effects of bariatric surgery on alcohol consumption. Addict Biol. 2017;22(6):1540-1553. doi:10.1111/ADB.12436
Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160-168. doi:10.1016/j.jhep.2013.03.007
Levene AP, Goldin RD. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology. 2012;61(2):141-152. doi:10.1111/J.1365-2559.2011.04145.X
Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: the gut microbiome and liver cross talk. Alcohol Clin Exp Res. 2015;39(5):763-775. doi:10.1111/acer.12704
Tobias DK, Hu FB. The association between BMI and mortality: implications for obesity prevention. Lancet Diabetes Endocrinol. 2018;6(12):916-917. doi:10.1016/S2213-8587(18)30309-7
Bhaskaran K, dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944-953. doi:10.1016/S2213-8587(18)30288-2
Hua R, Wang GZ, Shen QW, et al. Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice. Asian J Surg. 2021;44(1):213-220. doi:10.1016/J.ASJSUR.2020.05.030
Andolfi C, Fisichella PM. Epidemiology of obesity and associated comorbidities. J Laparoendosc Adv Surg Tech A. 2018;28(8):919-924. doi:10.1089/LAP.2018.0380
Chen G, Zhang GX, Peng BQ, Cheng Z, Du X. Roux-En-Y gastric bypass versus sleeve gastrectomy plus procedures for treatment of morbid obesity: systematic review and meta-analysis. Obes Surg. 2021;31(7):3303-3311. doi:10.1007/s11695-021-05456-0
Morton JM. The ASMBS textbook of bariatric surgery; 2020. doi:10.1007/978-3-030-27021-6
Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;15(2):CD003641. doi:10.1002/14651858.CD003641.PUB3
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279-2289. doi:10.1007/S11695-017-2666-X
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-1737. doi:10.1001/JAMA.292.14.1724
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926-932. doi:10.1007/S11695-015-1869-2
Ferstl P, Trebicka J. Acute decompensation and acute-on-chronic liver failure. Clin Liver Dis. 2021;25(2):419-430. doi:10.1016/J.CLD.2021.01.009
Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL). Hepatol Int. 2009;3(1):269-282. doi:10.1007/S12072-008-9106-X
Singh H, Pai CG. Defining acute-on-chronic liver failure: east, west or middle ground? World J Hepatol. 2015;7(25):2571-2577. doi:10.4254/WJH.V7.I25.2571
Li F, Thuluvath PJ. EASL-CLIF criteria outperform NACSELD criteria for diagnosis and prognostication in ACLF. J Hepatol. 2021;75(5):1096-1103. doi:10.1016/J.JHEP.2021.05.033
Verma N, Mehtani R, Duseja A. Universal definition and prognostication in acute-on-chronic liver failure - an unmet need! J Hepatol. 2022;76(1):241-242. doi:10.1016/j.jhep.2021.06.046
Moolenaar LR, De Waard NE, Heger M, et al. Liver injury and acute liver failure after bariatric surgery: an overview of potential injury mechanisms. J Clin Gastroenterol. 2022;56(4):311-323. doi:10.1097/MCG.0000000000001662
King WC, Chen JY, Courcoulas AP, et al. Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017;13(8):1392-1402. doi:10.1016/J.SOARD.2017.03.021
King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516-2525. doi:10.1001/jama.2012.6147
Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012;22(2):201-207. doi:10.1007/s11695-010-0346-1
Kanji S, Wong E, Aikioyamen L, Melamed O, Taylor VH. Exploring pre-surgery and post-surgery substance use disorder and alcohol use disorder in bariatric surgery: a qualitative scoping review. Int J Obes (Lond). 2019;43(9):1659-1674. doi:10.1038/S41366-019-0397-X
Conason A, Teixeira J, Hsu CH, Puma L, Knafo D, Geliebter A. Substance use following bariatric weight loss surgery. JAMA Surg. 2013;148(2):145-150. doi:10.1001/2013.JAMASURG.265
Miller-Matero LR, Hamann A, LaLonde L, et al. Predictors of alcohol use after bariatric surgery. J Clin Psychol Med Settings. 2021;28(3):596-602. doi:10.1007/S10880-020-09751-3
Maluenda F, Csendes A, De Aretxabala X, et al. Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity. Obes Surg. 2010;20(6):744-748. doi:10.1007/S11695-010-0136-9
Acevedo MB, Eagon JC, Bartholow BD, Klein S, Bucholz KK, Pepino MY. Sleeve gastrectomy surgery: when 2 alcoholic drinks are converted to 4. Surg Obes Relat Dis. 2018;14(3):277-283. doi:10.1016/J.SOARD.2017.11.010
Svensson PA, Anveden Å, Romeo S, et al. Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study. Obesity. 2013;21(12):2444-2451. doi:10.1002/oby.20397
Östlund MP, Backman O, Marsk R, et al. Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery. JAMA Surg. 2013;148(4):374-377. doi:10.1001/JAMASURG.2013.700
Lefere S, Onghena L, Vanlander A, Nieuwenhove Y, Devisscher L, Geerts A. Bariatric surgery and the liver-mechanisms, benefits, and risks. Obes Rev. 2021;22:e13294. doi:10.1111/obr.13294
Lefere S, Stroobant L, Verhelst X, et al. Bariatric surgery patients are at risk for alcoholic liver disease with need for liver transplantation. Obes Surg. 2020;30(11):4659-4664. doi:10.1007/S11695-020-04806-8
Spadola CE, Wagner EF, Dillon FR, Trepka MJ, De La Cruz-Munoz N, Messiah SE. Alcohol and drug use among postoperative bariatric patients: a systematic review of the emerging research and its implications. Alcohol Clin Exp Res. 2015;39(9):1582-1601. doi:10.1111/ACER.12805
Xu R, Zhu C, Pierre JF, Yin DP. Gastric bypass improves obesity and glucose tolerance independent of gastric pouch size. Obes Surg. 2020;30(5):1635-1641. doi:10.1007/s11695-020-04403-9
Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315-1322. doi:10.1016/J.SOARD.2015.02.006
Ayer A, Borel F, Moreau F, et al. Techniques of sleeve gastrectomy and modified Roux-en-y gastric bypass in mice. J Vis Exp. 2017;2017:54905. doi:10.3791/54905
Cerón-Solano G, Zepeda RC, Romero Lozano JG, Roldán-Roldán G, Morin JP. Bariatric surgery and alcohol and substance abuse disorder: a systematic review. Cir Esp. 2021;99(9):635-647. doi:10.1016/j.ciresp.2021.03.006
Pepino MY, Okunade AL, Eagon JC, Bartholow BD, Bucholz K, Klein S. Effect of Roux-en-Y gastric bypass surgery: converting 2 alcoholic drinks to 4. JAMA Surg. 2015;150(11):1096-1098. doi:10.1001/JAMASURG.2015.1884
Backman O, Stockeld D, Rasmussen F, Näslund E, Marsk R. Alcohol and substance abuse, depression and suicide attempts after Roux-en-Y gastric bypass surgery. Br J Surg. 2016;103(10):1336-1342. doi:10.1002/BJS.10258
Steffen KJ, Engel SG, Wonderlich JA, Pollert GA, Sondag C. Alcohol and other addictive disorders following bariatric surgery: prevalence, risk factors and possible etiologies. Eur Eat Disord Rev. 2015;23(6):442-450. doi:10.1002/ERV.2399
Acevedo MB, Teran-Garcia M, Bucholz KK, et al. Alcohol sensitivity in women after undergoing bariatric surgery: a cross-sectional study. Surg Obes Relat Dis. 2020;16(4):536-544. doi:10.1016/j.soard.2020.01.014
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-761. doi:10.1056/NEJMOA066603
Auge M, Menahem B, Savey V, Lee Bion A, Alves A. Long-term complications after gastric bypass and sleeve gastrectomy: what information to give to patients and practitioners, and why? J Visc Surg. 2022;159(4):298-308. doi:10.1016/j.jviscsurg.2022.02.004